Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oncolytics Biotech Inc
(NQ:
ONCY
)
0.9800
-0.0200 (-2.00%)
Streaming Delayed Price
Updated: 3:59 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Oncolytics Biotech Inc
< Previous
1
2
Next >
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
A Preview Of Oncolytics Biotech's Earnings
March 06, 2024
Via
Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Earnings Preview: Oncolytics Biotech
November 11, 2024
Via
Benzinga
Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer
August 14, 2024
Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer
Via
News Direct
ONCY Stock Earnings: Oncolytics Biotech Beats EPS for Q1 2024
May 09, 2024
ONCY stock results show that Oncolytics Biotech beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
ONCY Stock Earnings: Oncolytics Biotech Beats EPS for Q4 2023
March 07, 2024
ONCY stock results show that Oncolytics Biotech beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Recap: Oncolytics Biotech Q4 Earnings
March 07, 2024
Via
Benzinga
Oncolytics Biotech's Earnings Outlook
November 02, 2023
Via
Benzinga
Oncolytics Biotech's Earnings: A Preview
August 11, 2023
Via
Benzinga
5 Analysts Have This to Say About Oncolytics Biotech
June 29, 2023
Via
Benzinga
Expert Ratings for Oncolytics Biotech
May 26, 2023
Via
Benzinga
Oncolytics Biotech: Q1 Earnings Insights
May 05, 2023
Via
Benzinga
Earnings Scheduled For November 3, 2023
November 03, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.
Via
Benzinga
3 Under-$20 Stocks to Buy for Explosive Returns
August 21, 2023
Are you looking to invest in stocks with massive potential? Here are three under $20 stocks to buy for explosive returns.
Via
InvestorPlace
Oncolytics Biotech's Earnings: A Preview
May 04, 2023
Via
Benzinga
Oncolytics Biotech's Earnings: A Preview
March 02, 2023
Via
Benzinga
Earnings Scheduled For August 11, 2022
August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
Via
Benzinga
Earnings Scheduled For August 14, 2023
August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via
Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 22, 2023
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
May 24, 2023
Via
Benzinga
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 26, 2023
Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.
Via
Benzinga
Earnings Scheduled For March 3, 2023
March 03, 2023
Companies Reporting Before The Bell • Hibbett (NASDAQ:HIBB) is projected to report quarterly earnings at $2.99 per share on revenue of $479.64 million.
Via
Benzinga
Nasdaq Turns Lower; Dow Tumbles Over 300 Points
December 01, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 300 points on Thursday.
Via
Benzinga
Earnings Scheduled For May 5, 2023
May 05, 2023
Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly earnings at $0.32 per share on revenue of $5.08 billion.
Via
Benzinga
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
December 01, 2022
Gainers Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24. Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250.
Via
Benzinga
Recap: Oncolytics Biotech Q3 Earnings
November 07, 2022
Oncolytics Biotech (NASDAQ:ONCY) reported its Q3 earnings results on Monday, November 7, 2022 at 08:03 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
November 09, 2022
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Via
Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
November 08, 2022
Gainers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022
October 06, 2022
Upgrades
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.